Related Experiment Video
Updated: Jul 22, 2026

Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems
Published on: April 23, 2012
Human parvoviruses
1Respiratory and Enterovirus Branch, Centers for Disease Control, Atlanta, Georgia 30333.
Abstract:
Human parvovirus B19 is a common infection that causes a number of clinical illnesses, most of which are benign. However, in patients with a need for increased red cell production, a deficient immune system, or both (such as occurs in the fetus), it can be a life-threatening infection. Intravenous immunoglobulin should be considered in the treatment of chronic B19 infection in immunodeficient patients and possibly in the management of other serious B19 infections. Recent advances in the laboratory, especially the increased sensitivity of polymerase chain reaction assay for detecting B19 DNA and the development of a cell line that produces B19 proteins in the form of empty capsids, should lead to significant advances in our understanding, treatment, and management of B19 disease in the near future.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
07:58Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
Published on: May 22, 2026
Related Concept Videos
Viral Recombination
Retroviruses
Size and Structure of Viral Genomes
Human Virome
Bacteriophages of the Human Virome
Poliomyelitis